Roche Promotes Real-World Innovation through Excellence in Chemistry Symposium
News May 08, 2006
Aimed at providing graduate students with a real-world perspective on the role of organic chemistry in the drug discovery process, Roche has recently awarded 12 Ph.D. candidates and two professors the Excellence in Chemistry Award for their research accomplishments in the field of chemistry.
The award gave students and faculty an opportunity to participate in Roche's third annual chemistry symposium, designed to demonstrate the application of cutting-edge chemical research in a pharmaceutical setting.
The symposium alternates annually between Roche sites in Palo Alto, California and Nutley, New Jersey.
"The symposium is a unique opportunity to expose the awardees to life in the pharmaceutical industry while showcasing the cutting edge science Roche has to offer," said Dave Smith, principal research scientist and the organizer of this year's symposium.
"As a leading pharmaceutical company, we feel it is important that students are aware of the central role organic chemistry plays in the drug discovery process and that their expertise and dedication to chemistry are highly valued."
The symposium included talks covering the students' current research. Other activities included overviews of the drug discovery process by Roche scientists, case histories in medicinal and process chemistry, site tours that highlight the key technologies, and plenary lectures by this year's faculty awardees, Professors F. Dean Toste and John L. Wood, members of the University of California, Berkeley and Yale University Chemistry departments, respectively.
Each year, Roche chemists in Palo Alto and Nutley select the awardees jointly. 40 faculty members at 19 prominent universities were invited to nominate students to participate in the symposium.
Professors were asked to consider students who might be interested in the pharmaceutical industry and who are one to two years from completing their Ph.D. Submissions required a supporting letter from the nominee, the student's resume and a short research summary.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE